These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 22744707

  • 21. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.
    Salajegheh A, Pakneshan S, Rahman A, Dolan-Evans E, Zhang S, Kwong E, Gopalan V, Lo CY, Smith RA, Lam AK.
    Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470
    [Abstract] [Full Text] [Related]

  • 22. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
    Machens A, Dralle H.
    Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M, Wu W, Gao M, Fei Z.
    Cancer Biomark; 2017 Jul 04; 19(4):437-445. PubMed ID: 28582849
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of LC3 in Papillary Thyroid Carcinomas and Lymph Node Metastases.
    Li X, Lin X, Ma H.
    Acta Chir Belg; 2015 Jul 04; 115(5):356-63. PubMed ID: 26560002
    [Abstract] [Full Text] [Related]

  • 25. Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma.
    Choi YW, Kim YH, Lee J, Soh EY, Park TJ, Kim JH.
    Hum Pathol; 2015 Oct 04; 46(10):1557-65. PubMed ID: 26297257
    [Abstract] [Full Text] [Related]

  • 26. Role of laminin 332 in lymph node metastasis of papillary thyroid carcinoma.
    Oh KH, Choi J, Woo JS, Baek SK, Jung KY, Koh MJ, Kim YS, Kwon SY.
    Auris Nasus Larynx; 2017 Dec 04; 44(6):729-734. PubMed ID: 28238469
    [Abstract] [Full Text] [Related]

  • 27. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M, Gacquer D, Spinette A, Craciun L, Decaussin-Petrucci M, Andry G, Detours V, Maenhaut C.
    BMC Genomics; 2015 Oct 21; 16():828. PubMed ID: 26487287
    [Abstract] [Full Text] [Related]

  • 28. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D, Liu Y, Lin S, Tan L, Du Z, Long M, Zhu Y, Peng X, Zong W, Mackenzie GG, Li H, Ouyang N.
    Oncol Rep; 2019 Feb 21; 41(2):1253-1263. PubMed ID: 30535496
    [Abstract] [Full Text] [Related]

  • 29. [The characteristic of metabolics of female papillary thyroid carcinoma and its relationship with primary tumor size and cervical lymph node metastases].
    Zheng WJ, Xu YN, Zhou QY, Chen J, Fei MJ, Wang JD.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb 21; 51(2):105-11. PubMed ID: 26898866
    [Abstract] [Full Text] [Related]

  • 30. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
    Zhang J, Gill AJ, Issacs JD, Atmore B, Johns A, Delbridge LW, Lai R, McMullen TP.
    Hum Pathol; 2012 Jul 21; 43(7):1044-50. PubMed ID: 22204713
    [Abstract] [Full Text] [Related]

  • 31. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
    Wu G, Zhou Y, Li T, Guo J, Zhou Z.
    J Int Med Res; 2013 Jun 21; 41(3):816-24. PubMed ID: 23685894
    [Abstract] [Full Text] [Related]

  • 32. Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.
    He J, Jin Y, Zhou M, Li X, Chen W, Wang Y, Gu S, Cao Y, Chu C, Liu X, Zou Q.
    Cancer Sci; 2018 Mar 21; 109(3):642-655. PubMed ID: 29274137
    [Abstract] [Full Text] [Related]

  • 33. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
    Kim HS, Lee JJ, Do SI, Kim K, Do IG, Kim DH, Chae SW, Sohn JH.
    Int J Clin Exp Pathol; 2015 Mar 21; 8(5):5695-701. PubMed ID: 26191283
    [Abstract] [Full Text] [Related]

  • 34. Risk factors and clinical indication of metastasis to lymph nodes posterior to right recurrent laryngeal nerve in papillary thyroid carcinoma: a single-center study in China.
    Pinyi Z, Bin Z, Jianlong B, Yao L, Weifeng Z.
    Head Neck; 2014 Sep 21; 36(9):1335-42. PubMed ID: 23955992
    [Abstract] [Full Text] [Related]

  • 35. Functional analysis of three novel cell lines derived from human papillary thyroid carcinomas with three different clinical courses.
    Ishikawa M, Tachibana T, Hashimoto H, Toyomura J, Ito T, Tsuboi K, Shibuya K, Hirose T, Minami S, Yoshino G.
    Hum Cell; 2014 Jul 21; 27(3):111-20. PubMed ID: 24567186
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
    Šelemetjev S, Bartolome A, Išić Denčić T, Đorić I, Paunović I, Tatić S, Cvejić D.
    Int J Exp Pathol; 2018 Apr 21; 99(2):87-94. PubMed ID: 29665129
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ.
    Clin Cancer Res; 2003 Dec 15; 9(17):6534-44. PubMed ID: 14695158
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH, Shen WT, Gosnell J, Duh QY.
    Head Neck; 2015 Sep 15; 37(9):1336-43. PubMed ID: 24821456
    [Abstract] [Full Text] [Related]

  • 39. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
    Salter KD, Andersen PE, Cohen JI, Schuff KG, Lester L, Shindo ML, Sauer D, Gross ND.
    Arch Otolaryngol Head Neck Surg; 2010 Jul 15; 136(7):692-6. PubMed ID: 20644065
    [Abstract] [Full Text] [Related]

  • 40. [Role of level VI lymph nodes metastasis in cervical metastasis of patients with papillary thyroid cancer].
    Bian X, Chen H, Ye X, Tang PZ.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug 15; 45(8):664-8. PubMed ID: 21055244
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.